Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during the Q&A sessions that will follow each presentation. Please visit our web to join the digital events: https://hamletbiopharma.com/series-of-digital-events
The digital events are scheduled for:
- January 22, 2025, 12:00 CET
- March 12, 2025, 12:00 CET
- April 23, 2025, 12:00 CET
- June 18, 2025, 12:00 CET
Additionally, please note the following dates for quarterly reports this spring:
- February 13, 2025: Interim report (Q2) 2024/2025
- May 22, 2025: Interim Report (Q3) 2024/2025
Please visit our updated website at:
To receive information from the company, please subscribe at:
https://hamletbiopharma.com/subscribe/
For more information please contact:
Martin Erixon, CEO, Hamlet BioPharma AB, +46 733 00 43 77
martin.erixon@hamletpharma.com
Catharina Svanborg, Chairman of the board, Hamlet BioPharma AB, +46 709 42 65 49,
catharina.svanborg@hamletpharma.com
